SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal Females

Clinical trial NCT06467201 · COMPLETED

Trial details

NCT number: NCT06467201
Sponsor: Amneal Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Postmenopausal Women

Start date: 2024-06-03
Primary completion: 2024-12-08
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.